Advertisement
AGLE 外汇新闻
Aeglea BioTherapeutics President And CEO Anthony Quinn Steps Down
Biotechnology company Aeglea BioTherapeutics, Inc. (AGLE) announced Wednesday a leadership transition and corporate restructuring to focus resources on AGLE-177 in development for patients living with Homocystinuria.
RTTNews
|
1110天前
